Hepatitis C Virus Seroprevalence in Persons Who Inject Drugs in Korea, 2012-2022: A Multicenter, Retrospective Study.

Ji Hye Kim Gwang Hyeon Choi Ok-Jin Jang Younghoon Chon Sung Nam Cho Dohoon Kwon Sook-Hyang Jeong

Published in: Journal of Korean medical science (2023)

The HCV seroprevalence in PWID was 39.7% with a very low treatment rate, which prompts active measures to test and treat PWID for HCV infection in South Korea.

Keyphrases

hepatitis c virus
human immunodeficiency virus
cross sectional
combination therapy
smoking cessation